
|Videos|April 7, 2016
Patient-Specific Factors to Consider When Selecting a Novel Oral Anticoagulant
John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, talks about patient-specific factors to consider when selecting a novel oral anticoagulant.
Advertisement
John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, talks about patient-specific factors to consider when selecting a novel oral anticoagulant.
This video was recorded at APhA's 2016 Annual Meeting and Exposition in Baltimore, Maryland.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Clinical Data Support Use of Low-Carbon Version of Albuterol Metered Dose Inhaler for Asthma
2
States Push Forward on Insurance Mandates for GLP-1 and Obesity Treatments
3
FDA Expands Approval of Sotatercept-Csrk for Pulmonary Arterial Hypertension
4
Expert Insights on Key Data from IMS 2025
5














































































































































































































